Back to Search
Start Over
Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.
- Source :
-
Internal medicine journal [Intern Med J] 2020 Jul; Vol. 50 (7), pp. 798-804. - Publication Year :
- 2020
-
Abstract
- The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has emerged as a public health emergency and challenged healthcare systems globally. In a minority of patients, SARS-CoV-2 manifests with a severe acute respiratory illness and currently there is insufficient data regarding the virulence of COVID-19 in inflammatory bowel disease patients taking immunosuppressive therapy. This review aims to summarise the current literature and provide guidance on the management of inflammatory bowel disease patients in the context of the COVID-19 pandemic in the Australasian setting.<br /> (© 2020 Royal Australasian College of Physicians.)
- Subjects :
- Australia
Betacoronavirus isolation & purification
COVID-19
Change Management
Disease Management
Humans
Practice Guidelines as Topic
Risk Management
SARS-CoV-2
Coronavirus Infections epidemiology
Coronavirus Infections prevention & control
Gastroenterology organization & administration
Gastroenterology trends
Immunologic Factors pharmacology
Inflammatory Bowel Diseases epidemiology
Inflammatory Bowel Diseases immunology
Inflammatory Bowel Diseases therapy
Pandemics prevention & control
Patient Care Management methods
Patient Care Management trends
Pneumonia, Viral epidemiology
Pneumonia, Viral prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 1445-5994
- Volume :
- 50
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Internal medicine journal
- Publication Type :
- Academic Journal
- Accession number :
- 32656985
- Full Text :
- https://doi.org/10.1111/imj.14889